LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $2,970,000 | -14.5% | 110,000 | -12.0% | 0.98% | -28.5% |
Q3 2015 | $3,474,000 | +100.8% | 125,000 | -30.6% | 1.37% | +47.8% |
Q3 2014 | $1,730,000 | +88.5% | 180,000 | +80.0% | 0.92% | +115.9% |
Q2 2014 | $918,000 | -24.4% | 100,000 | -11.1% | 0.43% | -23.8% |
Q1 2014 | $1,215,000 | – | 112,500 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |